The financial toxicity of multiple sclerosis

pills alongside a pot of money

Multiple sclerosis (MS) is a neurologic autoimmune disease that is generally diagnosed in young adults. It is a lifelong condition, as it is currently incurable. The medical costs are high, as patients have to cover frequent hospital visits and prescription medications, such as emerging disease modifying drugs. As a result, many patients do not adhere to treatment plans, which further […]

Read More…

The role of CD83: Autoimmunity, transplantation and beyond

The role of CD83: Autoimmunity, transplantation and beyond

Professor Alexander Steinkasserer is based at the Department of Immune Modulation, University Hospital, Erlangen. His research interests are focused on the immune system, with the long-term aim to develop new therapeutic strategies for patients suffering from autoimmune disorders or in need of transplantation. Along with his colleagues at the department of Immune Modulation, Professor Steinkasserer has shed much light on […]

Read More…

Better together: How a multidisciplinary team is seeking new ways to tackle cognitive problems in MS patients

neurons in a patient's brain

Multiple sclerosis (MS) is a chronic disease affecting the brain and spinal cord. Symptoms vary between patients, and can range from fatigue and muscle stiffness to problems with vision and walking. Cognitive problems are relatively common among MS patients, affecting 40-60% of sufferers. These problems, which can include memory loss and difficulty multitasking, can have a significant impact on a person’s […]

Read More…

Patient and Public Involvement: A vital part of healthcare research

A PPI focus group

Patient and Public Involvement, or PPI, is an essential part of modern healthcare research. Patients are the only ones who truly understand what it is like to live with their condition and can therefore offer a uniquely valuable contribution to research. At the University of Nottingham, Professor Roshan das Nair and his colleagues have established a successful PPI group for […]

Read More…

Medicine’s digital future: Patients use App for automatic data collection in adherence study

People with chronic medical conditions, such as multiple sclerosis, often have to take the same medication for a long period of time. Unfortunately, medication adherence, or how good patients are at taking their medication as prescribed, is often low in this group. Prof Markus Schürks and Dr Christian Müller of Bayer Vital GmbH, Leverkusen, Germany, carried out a novel pilot […]

Read More…

BICAMS: Shedding light on cognition in Multiple Sclerosis

BICAMS Research Outreach

Multiple Sclerosis (MS) is a disease that attacks the central nervous system, leading to a variety of symptoms, across the physical and psychological domains. For many people with MS, symptoms can include difficulties with memory and thinking, which impacts on the quality of many aspects of their life. Dawn Langdon, Professor of Neuropsychology at Royal Holloway, University of London, has led an […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION